logo BDSP

Base documentaire

  1. Targeting pneumococcal vaccination to high-risk groups : a feasibility study in one general practice.

    Article - En anglais

    The Department of Health recommends pneumococcal vaccination opportunistically or when immunising against influenza.

    This was a study in one general practice to assess the feasibility of targeting patients for pneumococcal vaccination in primary care.

    We also examined the rate of uptake of pneumococcal vaccine in identified risk groups after one year of a pneumococcal vaccination programme.

    A self-administered questionnaire was given to patients attending for influenza vaccine between September and December 1996.

    A total of 551/747 (73.8%) patients returned completed questionnaires.

    Few patients receiving influenza vaccination (133/509,26%) were aware of pneumococcal vaccine.

    Only 55/108 (51%) of those given influenza vaccination were in a clinical risk group for pneumococcal vaccine.

    Attitudes towards vaccination were more positive and intention to take up pneumococcal vaccination significantly greater in high-risk patients compared to those who were not in a risk group.

    A targeted vaccination campaign directed at high-risk patients, both opportunistically and those attending for influenza vaccination over one year, resulted in the following proportions of patients in at-risk groups being vaccinated : coronary disease 144/312 (46%), diabetes 79/132 (60%), splenectomy 212 (100%), chronic obstructive airways disease and asthma 1351700 (19%), and chronic renal failure 5/9 (56%). (...)

    Mots-clés Pascal : Streptococcus pneumoniae, Streptococcaceae, Micrococcales, Bactérie, Vaccination, Audit, Grippe, Virose, Infection, Risque élevé, Indication, Faisabilité, Homme, Bactériose, Immunoprophylaxie, Prévention

    Mots-clés Pascal anglais : Streptococcus pneumoniae, Streptococcaceae, Micrococcales, Bacteria, Vaccination, Audit, Influenza, Viral disease, Infection, High risk, Indication, Feasibility, Human, Bacteriosis, Immunoprophylaxis, Prevention

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0218961

    Code Inist : 002B05A02. Création : 16/11/1999.